Sudden cardiac arrest (SCA) is one of the most devastating cardiovascular emergencies. SCA happens when the electrical system of the heart malfunctions, resulting in deadly arrhythmias, as opposed to a heart attack, which is brought on by limited blood supply to the heart muscle. Since survival rates are still poor, prevention is a top public health priority.
1 to 1.6 million sudden cardiac deaths occur in India every year. A study published in the Indian Heart Journal estimated that over 7,000 out-of-hospital cardiac arrests occur every day in India.
Role of Genetics
Genetics has become a potent tool for predicting and preventing SCA in recent years. Many occurrences are associated with hereditary heart problems, particularly in young people who do not appear to have any risk factors.
Several inherited syndromes and mutations predispose individuals to arrhythmias and structural heart disease, research has uncovered SNPs that play a role in conditions such as:
- Coronary artery disease (CAD): Variants in genes like 9p21, LPA, and APOB can increase plaque buildup risk.
- Hypertension: SNPs in the ACE and AGT genes can affect blood pressure regulation.
- Arrhythmias: Variants in genes regulating ion channels (like SCN5A) may predispose to rhythm abnormalities.
- Lipid metabolism disorders: SNPs in genes such as PCSK9 or LDLR can elevate cholesterol and triglyceride levels.
The importance of genetic testing is highlighted by the fact that these disorders are frequently silent until a catastrophic event occurs.
Who Should Consider Genetic Testing?
- Individuals with unexplained fainting, seizures, or palpitations.
- Survivors of cardiac arrest without a clear cause.
- Families with a history of sudden unexplained deaths.
- Patients with a proactive mindset.
The Future of SCA Prevention
Sudden Cardiac Arrest (SCA) remains one of the leading causes of cardiovascular mortality worldwide. With traditional risk assessment tools often failing to capture hidden genetic predispositions. The future is shifting toward preventive genetics and advancements in polygenic risk scores (PRS) are transforming preventive cardiology by integrating genetic data with clinical and lifestyle factors. This approach enables earlier identification of high-risk individuals, personalised intervention strategies, and a move from reactive treatment to proactive prevention.
____
Added keywords – Cardiovascular genetic testing, DNA test for health, genetic testing for disease.
Sudden cardiac arrest (SCA) is one of the most devastating cardiovascular emergencies. SCA happens when the electrical system of the heart malfunctions, resulting in deadly arrhythmias, as opposed to a heart attack, which is brought on by limited blood supply to the heart muscle. Since survival rates are still poor, prevention is a top public health priority, and cardiovascular genetic testing is increasingly being recognized as a key preventive approach.
Around 1 to 1.6 million sudden cardiac deaths occur in India every year. A study published in the Indian Heart Journal estimated that over 7,000 out-of-hospital cardiac arrests occur every day in India. These numbers highlight the urgent need for early risk detection through tools such as a DNA test for health and advanced genetic testing for disease.
Role of Genetics
Genetics has become a potent tool for predicting and preventing SCA in recent years. Many occurrences are associated with hereditary heart problems, particularly in young people who do not appear to have any conventional risk factors. Cardiovascular genetic testing helps identify inherited risks that may not be detected through routine clinical screening.
Several inherited syndromes and mutations predispose individuals to arrhythmias and structural heart disease. Research has uncovered SNPs that play a role in conditions such as:
- Coronary artery disease (CAD): Variants in genes like 9p21, LPA, and APOB can increase plaque buildup risk.
- Hypertension: SNPs in the ACE and AGT genes can affect blood pressure regulation.
- Arrhythmias: Variants in genes regulating ion channels (like SCN5A) may predispose individuals to rhythm abnormalities.
- Lipid metabolism disorders: SNPs in genes such as PCSK9 or LDLR can elevate cholesterol and triglyceride levels.
The importance of genetic testing for disease lies in the fact that many conditions remain clinically silent until a sudden and potentially fatal cardiac event occurs. Early detection through a DNA test for health enables timely monitoring, risk assessment, and preventive intervention.
Who Should Consider Genetic Testing?
- Individuals with unexplained fainting, seizures, or palpitations
- Survivors of cardiac arrest without a clear cause
- Families with a history of sudden unexplained deaths
- Patients with a proactive mindset toward long-term cardiovascular health
The Future of SCA Prevention
Sudden Cardiac Arrest (SCA) remains one of the leading causes of cardiovascular mortality worldwide. With traditional risk assessment tools often failing to capture hidden genetic predispositions, the future is shifting toward preventive genetics. Advancements in polygenic risk scores (PRS), combined with cardiovascular genetic testing, are transforming preventive cardiology by integrating genetic data with clinical and lifestyle factors. This approach enables earlier identification of high-risk individuals, personalized intervention strategies, and a move from reactive treatment to proactive prevention.
